Niaspan Buyers Ask 3rd Circ. For Rehearing On Class Cert.
Niaspan buyers told the Third Circuit that an appeals panel was wrong to reject their class certification bid based on the number of prescriptions at issue in their case accusing AbbVie...To view the full article, register now.
Already a subscriber? Click here to view full article